American Hemp Protection Act of 2025
Summary
HR6209 is an early-stage bill to repeal scheduled 2026 federal controls on hemp, restoring the 2018 Farm Bill's definition. The bill has zero funding attached, no committee movement in 5 months, and minimal near-term probability of passage. Real market data shows cannabis stocks (TLRY, CGC, SNDL) declining 10-14% in the last week, unrelated to this bill's stalled status.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR6209 is stalled in committee with 3 cosponsors after 5 months—very low probability of passage in the 119th Congress.
- 2.The bill authorizes $0 in spending; it is purely deregulatory—repealing a scheduled tightening of hemp product definitions.
- 3.Cannabis stocks (TLRY, CGC, SNDL) have declined 10-14% in the last week, unrelated to this bill's lack of progress.
- 4.If passed, the bill preserves the current legal market for hemp-derived cannabinoids but does not expand it—limited revenue upside for publicly traded companies.
- 5.The scheduled November 12, 2026 regulatory tightening remains the default unless this bill or similar legislation advances—a deadline that is 18 months away.
Market Implications
No near-term market impact. This bill is dead in the water for the 119th Congress based on action history. The real market data shows marijuana and hemp stocks (TLRY $6.14, CGC $1.09, SNDL $1.32) trading at or near their 52-week lows, reflecting sector-wide headwinds (regulatory uncertainty, state-level dynamics, capital constraints) rather than any pending legislative relief. The November 2026 regulatory deadline is the only concrete catalyst on the horizon, and it currently favors bearish positioning for hemp-exposed companies since repeal of that deadline requires legislative action that has not materialized.
Full Analysis
On November 20, 2025, Rep. Mace (R-SC) introduced HR6209, the American Hemp Protection Act of 2025. The bill targets section 781 of the FY2026 agriculture appropriations act (P.L. 119-37), which was set to tighten the legal definition of hemp products effective November 12, 2026. HR6209 would retroactively repeal that section, effectively restoring the 2018 Farm Bill's definition of hemp (cannabis with ≤0.3% delta-9 THC) for ALL hemp-derived products, including delta-8 THC and certain CBD extracts that were at risk of reclassification.
The bill authorizes zero dollars. It is a deregulatory repeal—no spending, no grants, no contracts. The money trail is purely regulatory: it prevents a scheduled tightening that would have narrowed the legal market for hemp-derived cannabinoids. The Congressional Budget Office would score this as reducing federal regulatory enforcement costs but generating no direct government spending.
The legislative path is weak. Five months after introduction, the bill remains in the House Committee on Agriculture with only 3 cosponsors (Mace, Massie, Lofgren, Baird). The 119th Congress is now well into its second session, and this bill has generated no additional action. Its primary sponsor is a junior member of the House (Rep. Mace). No companion bill exists in the Senate. The bill's passage probability is low in the current Congress.
Real market data from April 2026 shows cannabis-related stocks declining sharply: TLRY at $6.14 (7-day -11.53%, 52-wk range $3.50-$23.20), CGC at $1.09 (7-day -10.66%), SNDL at $1.32 (7-day -13.73%). These moves are consistent with broader market weakness, not legislative catalysts. The 30-day changes show mixed signals: CGC +26.74% (volatile small cap), TLRY +2.5%, SNDL +2.33%—these are not driven by HR6209's progress (none), but by company-specific factors and sector sentiment.
For investors: this bill is a low-probability event that would provide modest regulatory relief to hemp product companies. It has no direct revenue impact—its effect is avoiding a future negative regulatory shock. The tickers affected (TLRY, CGC, SNDL) have small U.S. hemp exposure relative to their total revenue. The most significant beneficiary would be hemp-specialty growers and processors not publicly listed in the U.S. (e.g., private CBD companies), not the multi-state operators whose primary business is high-THC cannabis.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Repeal of section 781 of P.L. 119-37, which would have reinstated federal controls on hemp products (e.g., moving some hemp extracts back toward controlled substance regulation). The bill restores the 2018 Farm Bill definition of hemp (≤0.3% delta-9 THC) for all hemp-derived products.
Who must act
Hemp cultivators, processors, and distributors—specifically companies in the U.S. hemp-derived cannabinoid supply chain relying on the 2018 Farm Bill's broad legal framework.
What happens
Prevents the November 12, 2026 scheduled tightening of federal regulatory controls on certain hemp derivatives (e.g., delta-8 THC, CBD extracts). Obligated parties avoid compliance costs, product bans, and market contraction that would have occurred under the new definition. The market for hemp-derived cannabinoids continues to operate under the current permissive federal baseline.
Stock impact
Tilray Brands' hemp segment (including Manitoba Harvest and its U.S. hemp beverage and CBD product lines) retains access to the broader legal market for hemp-derived cannabinoids. Avoided regulatory tightening preserves existing revenue streams from hemp-based foods, topicals, and extracts—estimated at low single-digit millions for Tilray's U.S. hemp business.
What the bill does
Same as above: repeal of the re-imposed federal controls on hemp products, restoring the 2018 Farm Bill definition for all hemp derivatives.
Who must act
U.S. hemp product manufacturers and distributors under federal jurisdiction.
What happens
Hemp-derived CBD and other cannabinoid product markets avoid a contraction scheduled for late 2026. Companies avoid sudden compliance costs, labeling restrictions, or ingredient prohibition tied to a narrower definition of legal hemp.
Stock impact
Canopy Growth's U.S. hemp strategy (mainly through BioSteel sports nutrition and its CBD wellness brand, Martha Stewart CBD) remains viable under the current legal framework. Avoided regulatory shock supports the segment's current revenue run rate. Canopy's core cannabis business is Canadian; hemp impact is modest relative to total revenue.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Hemp Planting Predictability Act
Proclamation: Further Adjusting the Tariff Regimes for Imports of Aluminum, Steel, and Copper into the United States
Combating Organized Retail Crime Act of 2025
Modern Worker Security Act
Executive Order: Restoring Integrity to America’s Financial System
Executive Order: Removing Unnecessary and Counterproductive Restrictions on Access to Federal Lands
H.R. 1 — Budget Reconciliation Act (One Big Beautiful Bill)
To expand the sharing of information with respect to suspected violations of intellectual property rights in trade.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Further Adjusting the Tariff Regimes for Imports of Aluminum, Steel, and Copper into the United States
This proclamation modifies existing Section 232 tariffs on aluminum, steel, and copper imports by expanding the list of derivative products eligible for a reduced 15% duty to include agricultural equipment and residential HVAC systems, temporarily reducing tariffs on mobile industrial equipment, adding aluminum lithographic plates and steel racks to the derivative tariff coverage, and lowering the threshold for products to qualify as made 'entirely' from American metals from 95% to 85%.
Removing Unnecessary and Counterproductive Restrictions on Access to Federal Lands
This executive order rescinds two 1970s-era executive orders (11644 and 11989) that required federal agencies to use vague environmental and social criteria when designating off-road vehicle use on federal lands. It directs the Secretaries of War, Interior, Agriculture, the TVA Board, and other relevant agency heads to initiate rulemakings to remove or revise regulations based on those criteria, aiming to increase access for energy, timber, utility maintenance, and recreation.
To Implement Certain Provisions in the Consolidated Appropriations Act, 2026, and for Other Purposes
This proclamation implements provisions of the Consolidated Appropriations Act, 2026, extending duty-free treatment under the African Growth and Opportunity Act (AGOA) through December 31, 2026, including the regional apparel article program and third-country fabric program. It also redesignates Gabon as a beneficiary sub-Saharan African country effective January 1, 2026, and extends preferential tariff treatment for Haiti under the Caribbean Basin Economic Recovery Act (CBERA) through December 31, 2026, with updated percentage limits for apparel imports. The proclamation directs modifications to the Harmonized Tariff Schedule of the United States (HTSUS) and authorizes agencies to implement these changes.